咨询与建议

看过本文的还看了

相关文献

该作者的其他文献

文献详情 >Challenges in managing ST elev... 收藏

Challenges in managing ST elevation myocardial infarction during the COVID-19 pandemic

作     者:Megan Smith Aniruddha Singh Douglas McElroy Shilpi Mittal Richard Pham 

作者机构:Department ofCardiologyUniversity of Kentucky College of MedicineBowling GreenKY 42101United States Department of CardiologyWestern Kentucky Heart and Lung Research FoundationBowling GreenKY 42101United States Department of CardiologyThe Medical CenterBowling GreenKY 42101United States Department of BiologyWestern Kentucky UniversityBowling GreenKY 42101United States Department of NeurologyVanderbilt University Medical CenterNashvilleTN 37232United States 

出 版 物:《World Journal of Cardiology》 (世界心脏病学杂志(英文版)(电子版))

年 卷 期:2021年第13卷第4期

页      面:76-81页

学科分类:1002[医学-临床医学] 100201[医学-内科学(含:心血管病、血液病、呼吸系病、消化系病、内分泌与代谢病、肾病、风湿病、传染病)] 10[医学] 

主  题:COVID-19 ST elevation myocardial infarction First medical contact to balloon Major adverse cardiac events Cardiac arrest Death 

摘      要:BACKGROUND Coronavirus disease 2019(COVID-19)may contribute to delayed presentations of acute myocardial *** presentation with late reperfusion is often associated with an increased risk of mechanical complications and adverse *** delays are possible as every patient who is acutely sick is being considered a potential case or a career of ***,standardized personal protective equipment precautions are established for all members of the team,regardless of pending COVID-19 testing which might further add to *** To compare performance measures and clinical outcomes of all patients who presented to our facility with ST elevation myocardial infarction(STEMI)during the COVID-19 pandemic to same time cohort from *** All patients who presented to our facility with STEMI during the pandemic were compared to a matched cohort during the same time period in *** with unknown time of symptom onset and inpatient STEMI patients were *** outcome was major adverse cardiac events(MACE)in-hospital and up to 14 d after STEMI,including death,myocardial infarction,cardiac arrest,or *** differences among groups for continuous variables were tested through ANOVA,using SYSTAT,version ***-square tests of association were used to compare patient characteristics among groups using *** risk scores and associated tests for significance were calculated for discrete variables using MedCalc(MedCalc Software,Ostend,Belgium).RESULTS There was a significantly longer time interval from symptom onset to first medical contact(FMC)in the COVID-19 group(P50%)lesion(s)remote from the culprit ***-hospital and 14 d MACE were more prevalent in the COVID-19 group

读者评论 与其他读者分享你的观点

用户名:未登录
我的评分